Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1101898 | 0.94 | PTGS1 (0.30) | PTGS1PTGS2 | |
| SCHEMBL7509227 | 0.91 | — | — | |
| SCHEMBL31337051 | 0.88 | PTGS1 (0.34) | PTGS1PTGS2 | |
| SCHEMBL15146790 | 0.88 | PTGS1 (0.31) | PTGS1PTGS2 | |
| SCHEMBL30831373 | 0.86 | PTGS1 (0.32) | PTGS1PTGS2 | |
| SCHEMBL5162214 | 0.86 | PTGS1 (0.34) | PTGS1PTGS2 | |
| SCHEMBL11075346 | 0.86 | PTGS1 (0.32) | PTGS1PTGS2 | |
| SCHEMBL1261863 | 0.86 | PTGS1 (0.32) | PTGS1PTGS2 | |
| SCHEMBL26726946 | 0.85 | — | — | |
| SCHEMBL16886919 | 0.85 | PTGS1 (0.31) | PTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240191078-A1 | ULTRAVIOLET-RAY-CURABLE COMPOSITION AND USE THEREOF | DOW TORAY CO LTD (JP) | 2024-06-13 | — | — | US | claimed |
| US-20240174889-A1 | ULTRAVIOLET-CURABLE COMPOSITION AND USE THEREOF | DOW TORAY CO LTD (JP) | 2024-05-30 | — | — | US | claimed |
| WO-2022203042-A1 | ULTRAVIOLET-RAY-CURABLE COMPOSITION AND USE THEREOF | ダウ・東レ株式会社 | 2022-09-29 | — | — | WO | claimed |
| WO-2022202498-A1 | ULTRAVIOLET-CURABLE COMPOSITION AND USE THEREOF | ダウ・東レ株式会社 | 2022-09-29 | — | — | WO | claimed |
| WO-2022102626-A1 | ULTRAVIOLET RAY CURABLE COMPOSITION AND APPLICATIONS THEREOF | ダウ・東レ株式会社 | 2022-05-19 | — | — | WO | claimed |
| US-8975357-B2 | Silicone modified fatty acids, method of preparation and usage thereof | NATURA INOVACAO E TECNOLOGIA DE PRODUTOS LTDA. (BR) | 2015-03-10 | — | — | US | claimed |
| EP-2620464-B1 | Silicone modified fatty acids, method of preparation and usage thereof | NATURA INOVAC O E TECNOLOGIA DE PRODUTOS LTDA (BR) | 2014-12-10 | — | — | EP | claimed |
| US-8846843-B2 | Silicone modified fatty acids, method of preparation and usage thereof | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2014-09-30 | — | — | US | claimed |
| EP-2473550-B1 | SILICONE MODIFIED FATTY ACIDS, METHOD OF PREPARATION AND USAGE THEREOF | MOMENTIVE PERFORMANCE MAT INC (US) | 2014-05-07 | — | — | EP | claimed |
| US-20130317105-A1 | SILICONE MODIFIED FATTY ACIDS, METHOD OF PREPARATION AND USAGE THEREOF | NATURA INOVACAO E TECNOLOGIA DE PRODUTOS LTDA. (BR) | 2013-11-28 | — | — | US | claimed |
| EP-2620464-A1 | Silicone modified fatty acids, method of preparation and usage thereof | Momentive Performance Materials Inc. (US) | 2013-07-31 | — | — | EP | claimed |
| US-20100040570-A1 | SILICONE MODIFIED FATTY ACIDS, METHOD OF PREPARATION AND USAGE THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2010-02-18 | — | — | US | claimed |
| US-20260022202-A1 | UV-CURABLE COMPOSITION AND USE THEREOF | DOW TORAY CO LTD (JP) | 2026-01-22 | — | — | US | disclosed |
| US-20250368774-A1 | ULTRAVIOLET-CURABLE COMPOSITION AND USE THEREOF | DOW TORAY CO LTD (JP) | 2025-12-04 | — | — | US | disclosed |
| WO-2025058306-A1 | EPOXY RESIN COMPOSITION FOR MOLDING | 주식회사 케이씨씨 | 2025-03-20 | — | — | WO | disclosed |
| WO-2025058307-A1 | EPOXY RESIN COMPOSITION FOR MOLDING | 주식회사 케이씨씨 | 2025-03-20 | — | — | WO | disclosed |
| US-20080287562-A1 | Stable cationically crosslinkable/polymerizable dental composition with a high filler content | RHODIA CHIMIE (FR) | 2008-11-20 | — | — | US | disclosed |
| US-20080064832-A1 | Cationically curable silicone compositions based on colloidal silica and anti-mist/anti-fouling hard coatings formed therefrom | RHODIA CHIMIE (FR) | 2008-03-13 | — | — | US | disclosed |
| US-7247660-B2 | Dental composition based on silicone crosslinkable by cation process | RHODIA CHIMIE (FR) | 2007-07-24 | — | — | US | disclosed |
| US-20070149636-A1 | Dental composition based on silicone crosslinkable by cation process | FRANCES JEAN-MARC | 2007-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130317105-A1 | SILICONE MODIFIED FATTY ACIDS, METHOD OF PREPARATION AND USAGE THEREOF | ASAH1, FASN, ASAH2 | PTGS1 905/4885PTGS2 864/4885 |
| US-20080287562-A1 | Stable cationically crosslinkable/polymerizable dental composition with a high filler content | RFC1, RFC2, HNRNPC | PTGS1 1535/4885PTGS2 1393/4885 |
| US-20100040570-A1 | SILICONE MODIFIED FATTY ACIDS, METHOD OF PREPARATION AND USAGE THEREOF | FASN, ELOVL5, SCD5 | PTGS1 700/4885PTGS2 662/4885 |
| US-20260022202-A1 | UV-CURABLE COMPOSITION AND USE THEREOF | IDUA, SEM1, ARSA | PTGS1 2446/4885PTGS2 2894/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.